Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Epredia™ Lab Vision™ Prostate Specific Membrane Antigen (PSMA) Rabbit Monoclonal Antibody, supernatant

Epredia™ Lab Vision™ Prostate Specific Membrane Antigen (PSMA) Rabbit Monoclonal Antibody, supernatant

Catalog No. RM9131S0 Shop All Epredia Products
Change view
Click to view available options
Quantity:
100 μL
1 mL
7 mL
12 mL
Form:
Concentrated
Prediluted
Ready-to-Use
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity Form
RM9131S0 100 μL Concentrated
RM9131S 1 mL Concentrated
RM9131R1 1 mL Prediluted
RM9131R7 7 mL Prediluted
RM9131RQ 12 mL Ready-to-Use
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
Catalog No. RM9131S0 Supplier Epredia™ Supplier No. RM9131S0

Description

Employ part of a comprehensive antibody portfolio with the Epredia™ Prostate Specific Membrane Antigen, Rabbit Monoclonal Antibody. Studies show rabbit monoclonal antibodies are more sensitive and specific than other available markers.

Prostate Specific Membrane Antigen (PSMA) is a surface glycoprotein with restricted expression to normal prostate tissue, primary and metastatic prostate cancer and the neovasculature of various nonprostatic epithelial malignancies. Overexpression of PSMA is correlated with high tumor grade, non-diploid tumors, and advanced tumor stage. Even though PSA is useful in identifying the prostate origin of cancers, PSMA shows moderate to strong positivity in one-half of the cells per case that show relatively poor PSA staining, and is excellent in differentiating between prostatic adenocarcinoma and urothelial carcinoma. PSMA is expressed in 94.3% to 100% of primary and 57.7% to 100% of metastatic prostatic carcinomas. PSMA is recognized as a viable target for cancer therapy.

Host Species: Rabbit

Clone: SP29

Species Reactivity: Human. Others not known.

Immunogen: C-terminal

Molecular Weight: 84kDa

Positive Control: Prostate carcinoma

Cellular Localization: Cytoplasmic and membrane

Recommended for:

  • Immunohistochemistry (Formalin/paraffin)

Specifications

Antigen Prostate Specific Membrane Antigen (PMSA)
Applications Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone SP29
Conjugate Unconjugated
Host Species Rabbit
Immunogen C-terminal
Quantity 100 μL
Regulatory Status IVD
Research Discipline Cancer and Tumor Biology
Primary or Secondary Primary
Target Species Human
Form Concentrated
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.